Effect of Periodontal Treatment on Visfatin, fetuin-a and Sirtuin 1 of Patients With Periodontitis and Type 2 Diabetes
Effect of Non-surgical Periodontal Treatment on Visfatin, fetuin-a and Sirtuin 1 Concentrations in Gingival Crevicular Fluid of Patients With Periodontitis and Type 2 Diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Samsun, Turkey, 55270
- Ondokuz Mayıs University, Faculty of Dentistry, Department of Periodontology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Volunteering to participate in the study
- To be over 18 years old
- No periodontal treatment in the last 6 months
- Being systemically healthy except for type 2 diabetes
- Not taking medication for any reason except type 2 diabetes
- HbA1c <7 in controlled Type 2 diabetes group
- HbA1c ≥7 in uncontrolled Type 2 diabetes group
- Not smoking or drinking alcohol
Exclusion Criteria:
- Not volunteering to participate in the study
- Under 18 years of age
- Periodontal treatment in the last 6 months
- Having any systemic disease affecting the periodontal condition
- Having used local or systemic antibiotics in the last 3 months
- Use of anti-inflammatory, steroid drugs in the last 3 months
- Taking vitamin, mineral or antioxidant supplements in the last 3 months
- Being pregnant or lactating
- Regular use of mouthwash
- Smoking or drinking alcohol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: group 1: Systemically Healthy, Periodontally Healthy (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment level were measured at 6 sites (buccomesial, midbuccal, buccodistal, lingual/palatal mesial, midlingual/palatal, lingual/palatal distal) of each tooth to evaluate the periodontal status of the patients.
On the day of examination, panoramic radiographs were taken from all patients to determine alveolar bone loss.
Gingival crevicular fluid is collected from the patients.
Gingival crevicular fluid samples were collected from 5 randomly selected teeth with GI=0, PI=0 and PPD ≤3.
Then, each paper strip from each tooth was individually placed in sterile 0.5 ml eppendorf tubes.
Eppendorf tubes were stored at -80°C.
Oral hygiene education was given to each patient.
Modified Bass technique was explained as a brushing technique.
Interdental brush or dental floss was recommended for interdental cleaning according to the condition of the patient's interdental areas and its use was demonstrated.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
|
|
Experimental: group 2: Systemically Healthy, Periodontitis (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment levels were measured from 6 sites of each tooth to evaluate the periodontal status of the patients.
Panoramic radiographs were taken from all patients.
Vertical/horizontal bone loss on the radiographs was evaluated to determine the stage and grade of periodontitis.
Gingival crevicular fluid samples were collected from the 5 periodontal pockets with the deepest PPD before and 3 months after treatment.
Eppendorf tubes were stored at -80°C.
Non-surgical periodontal treatments were started under local anesthesia.
Oral hygiene education was given to each patient after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning was explained.
The patient was told not to use any chemical agent for plaque removal.
3 months after the treatment gingival crevicular fluid samples are collected and clinical examination parameters were measured again.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
After clinical periodontal parameters were recorded and GCF samples were obtained, non-surgical periodontal treatment was started under local anesthesia.
All periodontal treatments were performed by a single investigator.
Local infiltrative anesthesia was applied to the buccal and palatal/lingual areas of the maxilla and mandible of the patients.
After anesthesia was achieved, scaler and ultrasonic tips of various thicknesses were used together to remove supragingival and subgingival hard attachments.
Root surface smoothing was performed with region-specific periodontal curettes.
The roughness of the surfaces was controlled using a periodontal probe.
Polishing was performed.
Oral hygiene education was given to each patient after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning is explained.
The patient was told not to use any chemical agent for plaque removal.
|
|
Experimental: grup 3: Controlled Type 2 Diabetes, Periodontally Healthy (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment level were measured at 6 sites (buccomesial, midbuccal, buccodistal, lingual/palatal mesial, midlingual/palatal, lingual/palatal distal) of each tooth to evaluate the periodontal status of the patients.
On the day of examination, panoramic radiographs were taken from all patients to determine alveolar bone loss.
HbA1c values were measured.
Gingival crevicular fluid is collected from the patients.
Gingival crevicular fluid samples were collected from 5 randomly selected teeth with GI=0, PI=0 and PPD ≤3.
Then, each paper strip from each tooth was individually placed in sterile 0.5 ml eppendorf tubes.
Eppendorf tubes were stored at -80°C.
Oral hygiene education was given to each patient.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning was explained.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
Blood samples were taken from the patients and HbA1c concentration was measured in serum.
|
|
Experimental: group 4: Controlled Type 2 Diabetes, Periodontitis (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment levels were measured from 6 sites of each tooth to evaluate the periodontal status of the patients.
Panoramic radiographs were taken from all patients.
Vertical/horizontal bone loss on the radiographs was evaluated to determine the stage and grade of periodontitis.
HbA1c levels are determined.
Gingival crevicular fluid samples were collected from the 5 periodontal pockets with the deepest PPD before and 3 months after treatment.
Samples were stored at -80°C.
Non-surgical periodontal treatments were started under local anesthesia.
Oral hygiene education was given after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning was explained.
The patient was told not to use any chemical agent for plaque removal.
3 months after the treatment gingival crevicular fluid samples are collected and clinical examination parameters were measured again.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
After clinical periodontal parameters were recorded and GCF samples were obtained, non-surgical periodontal treatment was started under local anesthesia.
All periodontal treatments were performed by a single investigator.
Local infiltrative anesthesia was applied to the buccal and palatal/lingual areas of the maxilla and mandible of the patients.
After anesthesia was achieved, scaler and ultrasonic tips of various thicknesses were used together to remove supragingival and subgingival hard attachments.
Root surface smoothing was performed with region-specific periodontal curettes.
The roughness of the surfaces was controlled using a periodontal probe.
Polishing was performed.
Oral hygiene education was given to each patient after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning is explained.
The patient was told not to use any chemical agent for plaque removal.
Blood samples were taken from the patients and HbA1c concentration was measured in serum.
|
|
Experimental: grup 5: Uncontrolled Type 2 Diabetes, Periodontally Healthy (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment level were measured at 6 sites (buccomesial, midbuccal, buccodistal, lingual/palatal mesial, midlingual/palatal, lingual/palatal distal) of each tooth to evaluate the periodontal status of the patients.
On the day of examination, panoramic radiographs were taken from all patients to determine alveolar bone loss.
HbA1c values were measured.
Gingival crevicular fluid is collected from the patients.
Gingival crevicular fluid samples were collected from 5 randomly selected teeth with GI=0, PI=0 and PPD ≤3.
Then, each paper strip from each tooth was individually placed in sterile 0.5 ml eppendorf tubes.
Eppendorf tubes were stored at -80°C.
Oral hygiene education was given to each patient.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning was explained.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
Blood samples were taken from the patients and HbA1c concentration was measured in serum.
|
|
Experimental: group 6: Uncontrolled Type 2 Diabetes, Periodontitis (n:11)
Plaque index, gingival index, bleeding on probing index, probing pocket depth and clinical attachment levels were measured from 6 sites of each tooth to evaluate the periodontal status of the patients.
Panoramic radiographs were taken from all patients.
Vertical/horizontal bone loss on the radiographs was evaluated to determine the stage and grade of periodontitis.
HbA1c levels are determined.
Gingival crevicular fluid samples were collected from the 5 periodontal pockets with the deepest PPD before and 3 months after treatment.
Samples were stored at -80°C.
Non-surgical periodontal treatments were started under local anesthesia.
Oral hygiene education was given after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning was explained.
The patient was told not to use any chemical agent for plaque removal.
3 months after the treatment gingival crevicular fluid samples are collected and clinical examination parameters were measured again.
|
Prior to GCF (gingival crevicular fluid) sampling, supragingival plaque was removed by sterile curets and, after air drying, the surfaces were isolated by cotton rolls.
Gingival fluid collection strips were placed in sulcus for 30s.
Care was taken not to avoid mechanical trauma and strips contaminated with blood or saliva were discarded.
The absorbed GCF volume was estimated by a calibrated instrument.
Then, the strips were sealed into sterile tubes before freezing at -80 °C.
The readings were converted to an actual volume (μl) by reference to the standard curve.
After clinical periodontal parameters were recorded and GCF samples were obtained, non-surgical periodontal treatment was started under local anesthesia.
All periodontal treatments were performed by a single investigator.
Local infiltrative anesthesia was applied to the buccal and palatal/lingual areas of the maxilla and mandible of the patients.
After anesthesia was achieved, scaler and ultrasonic tips of various thicknesses were used together to remove supragingival and subgingival hard attachments.
Root surface smoothing was performed with region-specific periodontal curettes.
The roughness of the surfaces was controlled using a periodontal probe.
Polishing was performed.
Oral hygiene education was given to each patient after treatment.
Modified Bass technique was explained as a brushing technique.
Interdental cleaning is explained.
The patient was told not to use any chemical agent for plaque removal.
Blood samples were taken from the patients and HbA1c concentration was measured in serum.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plaque index (PI)
Time Frame: Baseline to 3 months after treatment
|
PI was increased in all periodontitis patients with or without type 2 diabetes.
Type 2 diabetes has no effect on PI in periodontitis patients.
PI was reduced after non-surgical periodontal treatment (NSPT).
|
Baseline to 3 months after treatment
|
|
Gingival index (GI)
Time Frame: Baseline to 3 months after treatment
|
GI was increased in all periodontitis patients with or without type 2 diabetes.
Type 2 diabetes has no effect on GI in periodontitis patients.
GI was reduced after NSPT.
|
Baseline to 3 months after treatment
|
|
Bleeding on probing index (BPI)
Time Frame: Baseline to 3 months after treatment
|
BPI was increased in all periodontitis patients with or without type 2 diabetes.
Type 2 diabetes has no effect on BPI in periodontitis patients.
BPI was reduced after NSPT.
|
Baseline to 3 months after treatment
|
|
Probable pocket depth (PPD)
Time Frame: Baseline to 3 months after treatment
|
PPD was increased in all periodontitis patients with or without type 2 diabetes.
Type 2 diabetes has no effect on PPD in periodontitis patients.
PPD was reduced after NSPT.
|
Baseline to 3 months after treatment
|
|
Clinical attachment level (CAL)
Time Frame: Baseline to 3 months after treatment
|
CAL was increased in all periodontitis patients with or without type 2 diabetes.
Type 2 diabetes has no effect on CAL in periodontitis patients.
CAL was reduced after NSPT.
|
Baseline to 3 months after treatment
|
|
HbA1c level in blood plasma
Time Frame: Baseline to 3 months after treatment
|
NSPT reduced HbA1c levels of patients with type 2 diabetes.
|
Baseline to 3 months after treatment
|
|
Gingival crevicular fluid (GCF) quantity
Time Frame: Baseline to 3 months after treatment
|
The amount of gingival crevicular fluid was not affected by periodontal status in patients with Type 2 diabetes.
|
Baseline to 3 months after treatment
|
|
Visfatin concentration in GCF
Time Frame: Baseline to 3 months after treatment
|
Visfatin concentrations in GCF were increased in all periodontitis patients.
In periodontal healthy patients with Type 2 diabetes visfatin concentrations in GCF were increased.
Non-surgical periodontal treatment decreased the concentration of visfatin in GCF.
|
Baseline to 3 months after treatment
|
|
Fetuin-A concentration in GCF
Time Frame: Baseline to 3 months after treatment
|
Fetuin-A concentrations in GCF were decreased in all periodontitis patients.
In periodontal healthy patients with Type 2 diabetes fetuin-A concentrations in GCF were increased.
Non-surgical periodontal treatment increased the concentration of fetuin-A in GCF.
|
Baseline to 3 months after treatment
|
|
Sirtuin 1 concentration in GCF
Time Frame: Baseline to 3 months after treatment
|
In systemic healthy individuals, periodontitis decreased the concentration of sirtuin 1 in GCF.
Type 2 diabetes increased sirtuin 1 concentration in GCF.
In controlled type 2 diabetes patients with periodontitis sirtuin 1 concentrations in GCF were increased.
In uncontrolled type 2 diabetes patients with periodontitis sirtuin 1 concentrations in GCF were decreased.
Non-surgical periodontal treatment increased the concentration of sirtuin 1 in GCF.
|
Baseline to 3 months after treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Burcu OZKAN CETINKAYA, Prof., Ondokuzmayis University, Faculty of Dentistry, Department of Periodontology, Samsun, Turkey.
- Principal Investigator: Aysun AYDEMIR INAM, Dr., Ondokuzmayis University, Faculty of Dentistry, Department of Periodontology, Samsun, Turkey.
- Study Chair: Bahattin AVCI, Prof., Ondokuzmayis University, Faculty of Medicine Department of Biochemistry, Samsun, Turkey.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- B.30.2.ODM.0.20.08/462
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.